【港股异动 | 中国抗体-B(03681.HK)涨超18% 公司撤回舒西利单抗治疗RA上市申请 该药具备治疗SLE潜力】

智通财经
16 Jul
【港股异动 | 中国抗体-B(03681.HK)涨超18% 公司撤回舒西利单抗治疗RA上市申请 该药具备治疗SLE潜力】智通财经APP获悉,中国抗体-B(03681.HK)涨超18%,截至发稿,17.48%,报2.42港元,成交额5080.39万港元。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10